Summaries of oral sessions at the XXI World Congress of Psychiatric Genetics, Boston, Massachusetts, 17-21 October 2013: state of the field.

Psychiatr Genet

aMeharry Medical College, Nashville, Tennessee bHuman Genetics Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland cSection of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, Illinois dWashington University School of Medicine at Washington University Medical Center, St Louis, Missouri eHarvard Medical School, VA Boston Healthcare System, Brockton, Massachusetts fHospital for Sick Children, Toronto, Ontario, USA gDepartment of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Japan hThe Weizmann Institute of Science, Rehovot, Israel iMax-Planck Institute of Psychiatry, Munich jSection on Psychiatric Genetics, University Medical Center, University of Goettingen, Goettingen kDepartment of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany lDepartment of Psychiatry, Yuli Mental Health Research Center, Yuli Branch, Taipei Veterans General Hospital, Yuli mInstitute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan nInstitute of Psychiatry, Department of Biomedical and Neuromotor Science - DIBINEM, University of Bologna, Bologna, Italy oDepartment of General Biology, Fluminense Federal University, Rio de Janeiro, Brazil pMRC Centre for Neuropsychiatric Genetics and Genomic, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff qMedical Research Council Functional Genomics Unit, Department of Physiology, Anatomy, and Genetics rThe Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK sDepartment of Psychiatry and Neuropsychiatric Genetics Research Group, Trinity College Dublin, Trinity Centre for Health Sciences, St James's Hospital, Dublin, Ireland tNeurosciences, Molecular Genetics Laboratory, Neurobiology Research Center, National Institute of Mental Health and Neurosciences uNe

Published: August 2014

The XXI World Congress of Psychiatric Genetics (WCPG), sponsored by the International Society of Psychiatric Genetics (ISPG), took place in Boston, Massachusetts, on 17-21 October 2013. Approximately 900 participants gathered to discuss the latest findings in this rapidly advancing field. The following report was written by student travel awardees. Each was assigned one or more sessions as a rapporteur. This manuscript represents topics covered in most, but not all of the oral presentations during the conference, and contains some of the major notable new findings reported.

Download full-text PDF

Source
http://dx.doi.org/10.1097/YPG.0000000000000043DOI Listing

Publication Analysis

Top Keywords

psychiatric genetics
12
xxi congress
8
congress psychiatric
8
boston massachusetts
8
massachusetts 17-21
8
17-21 october
8
october 2013
8
summaries oral
4
oral sessions
4
sessions xxi
4

Similar Publications

Unidirectional and bidirectional causation between smoking and blood DNA methylation: evidence from twin-based Mendelian randomisation.

Eur J Epidemiol

January 2025

Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, 800 E. Leigh St., Suite 100, Richmond, VA, 23298, USA.

Cigarette smoking is associated with numerous differentially-methylated genomic loci in multiple human tissues. These associations are often assumed to reflect the causal effects of smoking on DNA methylation (DNAm), which may underpin some of the adverse health sequelae of smoking. However, prior causal analyses with Mendelian Randomisation (MR) have found limited support for such effects.

View Article and Find Full Text PDF

Background: The IDEAL study is a randomized clinical trial investigating the psychosocial, behavioral, and cognitive impacts of genetic risk disclosure for late-onset Alzheimer's disease (LOAD) among Latinos.

Methods: We used address-based sampling in northern Manhattan to recruit Latinos aged 40-64 for a community-based survey and clinical trial. Data collection encompasses demographics, Alzheimer's disease (AD) family history, knowledge and beliefs about AD and genetics, current mental health status, acculturation, impact of COVID-19, familism, fatalism, caregiver status, and prior AD genetic testing.

View Article and Find Full Text PDF

Background: High blood pressure (BP) level and variability has been linked to stroke, cerebral small vessel disease (CSVD), cognitive decline, and dementia. However, it is unclear whether sex/gender influences the association of BP level and variability with CSVD. Therefore, we aimed to examine sex-differences in the association of CSVD with 24-h BP level and variability.

View Article and Find Full Text PDF

Background: Cognitive impairment is associated with mortality. However, evidence using population-based studies is scarce, is limited to one cognitive assessment, and lacks the inclusion of non-fatal adverse health outcomes. Therefore, we aimed this study to (i) investigate the association of cognitive function with mortality and cardiovascular risk and (ii) determine whether cognitive tests improve the risk-stratification of endpoints beyond conventional risk factors.

View Article and Find Full Text PDF

Background: The increasing number of natural disasters and wars will result in complex emergencies affecting how individuals age. Additionally, the continued complex crises in certain areas of the globe exacerbates risks for chronic health conditions and poverty. Implementing ethical and community-engaged research in these complex humanitarian settings requires tailored approaches.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!